[1]
|
Mueller, P.R., Coleman, T.R., Kumagai, A. and Dunphy, W.G. (1995) Myt1: A Membrane-Associated Inhibitory Kinase That Phosphorylates Cdc2 on Both Threonine-14 and Tyrosine-15. Science, 270, 86-90.
https://doi.org/10.1126/science.270.5233.86
|
[2]
|
Schmidt, M., Rohe, A., Platzer, C., Najjar, A., Erdmann, F. and Sippl, W. (2017) Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases. Molecules, 22, 2045. https://doi.org/10.3390/molecules22122045
|
[3]
|
Mueller, P.R., Coleman, T.R., Kumagai, A. and Dunphy, W.G. (1995) Myt1: A Membrane-Associated Inhibitory Kinase That Phosphorylates Cdc2 on Both Threonine-14 and Tyro-sine-15. Science, 270, 86-90.
https://doi.org/10.1126/science.270.5233.86
|
[4]
|
van Vugt, M.A., Brás, A. and Medema, R.H. (2004) Polo-Like Kinase-1 Controls Recovery from a G2 DNA Damage-Induced Arrest in Mammalian Cells. Molecular Cell, 15, 799-811. https://doi.org/10.1016/j.molcel.2004.07.015
|
[5]
|
Ghelli Luserna di Rorà, A., Cerchione, C., Martinelli, G. and Simonetti, G. (2020) A WEE1 Family Business: Regulation of Mitosis, Cancer Progression, and Therapeutic Target. Journal of Hematology & Oncology., 13, 126.
https://doi.org/10.1186/s13045-020-00959-2
|
[6]
|
张琦, 赵鑫, 张春, 等. 过表达PKMYT1促进肿瘤进展, 与食管鳞癌生存率低有关[J]. 癌症管理, 2019(11): 7813-7824.
|
[7]
|
孙炽生, 罗敏, 赵海, 等. PKMYT1的过表达表明非小细胞肺癌预后不良, 并通过激活Notch信号通路增强非小细胞肺癌的增殖和肿瘤发生[J]. 欧洲医学药理学(修订版), 2019(23): 4210-4219.
|
[8]
|
Liu, Y., Qi, J., Dou, Z., Hu, J., Lu, L., Dai, H., Wang, H. and Yang, W. (2020) Systematic Expression Analysis of WEE Family Kinases Reveals the Importance of PKMYT1 in Breast Carcinogenesis. Cell Proliferation, 53, e12741.
https://doi.org/10.1111/cpr.12741
|
[9]
|
Zhang, Q.Y., Chen, X.Q., Liu, X.C. and Wu, D.M. (2020) PKMYT1 Pro-motes Gastric Cancer Cell Proliferation and Apoptosis Resistance. OncoTargets and Therapy, 13, 7747-7757. https://doi.org/10.2147/OTT.S255746
|
[10]
|
赵璇, 王海, 张新恩, 等. PKMYT1通过靶向SIRT3加重卵巢癌的进展[J]. 欧洲医学药理学(修订版), 2020(24): 5259-5266.
|
[11]
|
刘林, 吴军, 王淑, 等. PKMYT1通过激活β-连环蛋白/TCF信号传导促进肝细胞癌细胞的生长和运动[J]. 实验细胞研究, 2017(358): 209-216.
|
[12]
|
Chayka, O., D’Acunto, C.W., Middleton, O., Arab, M. and Sala, A. (2015) Identification and Pharmacological Inactivation of the MYCN Gene Network as a Therapeutic Strategy for Neuroblastic Tumor Cells. Journal of Biological Chemistry, 290, 2198-212. https://doi.org/10.1074/jbc.M114.624056
|
[13]
|
姚鹏程. 基于TCGA数据的肿瘤预后相关基因数据库的构建[D]: [硕士学位论文]. 成都: 电子科技大学, 2020.
https://doi.org/10.27005/d.cnki.gdzku.2020.004516
|
[14]
|
Cancer International Agency for Research on Cancer (2020) Cancer Today 2020. https://gco.iarc.fr/today/home
|
[15]
|
Villanueva, A. (2019) Hepatocellular Carcinoma. The New England Journal of Medicine, 380, 1450-1462.
https://doi.org/10.1056/NEJMra1713263
|
[16]
|
Yang, W.S., Zeng, X.F., Liu, Z.N., et al. (2020) Diet and Liver Cancer Risk: A Narrative Review of Epidemiologcal Evidence. British Journal of Nutrition, 124, 330-340. https://doi.org/10.1017/S0007114520001208
|
[17]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomata-ram, I., Jemal, A. and Bray, F. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[18]
|
章峥. 基于TCGA数据库肺鳞癌相关基因筛选及CCNB1 mRNA表达的预后分析[D]: [硕士学位论文]. 大理: 大理大学, 2021. https://doi.org/10.27811/d.cnki.gdixy.2021.000422
|
[19]
|
王娜娜, 江楠, 杨晓庆, 房磊, 孙青. 非小细胞肺癌组织起源分子病理分类及其临床意义[J]. 中国肺癌杂志, 2018, 21(7): 530-535.
|
[20]
|
Vander Heiden, M.G., Cantley, L.C. and Thompson, C.B. (2009) Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science, 324, 1029-1033. https://doi.org/10.1126/science.1160809
|
[21]
|
Pavlova, N.N. and Thompson, C.B. (2016) The Emerging Hallmarks of Cancer Metabolism. Cell Metabolism, 23, 27-47. https://doi.org/10.1016/j.cmet.2015.12.006
|
[22]
|
李权峰. PKMYT1抑制AKT磷酸化及非小细胞肺癌细胞生长的研究[D]: [硕士学位论文]. 广州: 南方医科大学, 2022. https://doi.org/10.27003/d.cnki.gojyu.2022.000637
|
[23]
|
Trayes, K.P. and Cokenakes, S.E.H. (2021) Breast Cancer Treatment. American Family Physician, 104, 171-178.
|
[24]
|
Chen, W., Zheng, R., Baade, P.D., et al. (2020) Cancer Sta-tistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[25]
|
Liu, L., Wu, J., Wang, S., et al. (2017) PKMYT1 Promoted the Growth and Motility of Hepatocellular Carcinoma Cells by Activating β-Catenin/TCF Signaling. Experimental Cell Research, 358, 209-216.
https://doi.org/10.1016/j.yexcr.2017.06.014
|
[26]
|
Attard, G., Parker, C., Eeles, R.A., et al. (2016) Prostate Cancer. The Lancet, 387, 70-82.
https://doi.org/10.1016/S0140-6736(14)61947-4
|
[27]
|
杨进益, 杨明州, 魏伟, 等. 前列腺癌发生发展的流行病学研究[J]. 临床泌尿外科杂志, 2017, 32(9): 721-725.
|
[28]
|
王嘉南. 间充质干细胞通过PKMYT1-CCNB1/CCNE1通路影响前列腺癌进展机制研究[D]: [博士学位论文]. 天津: 天津医科大学, 2019. https://doi.org/10.27366/d.cnki.gtyku.2019.001251
|
[29]
|
王茂宇. PKMYT1在膀胱癌中的表达及其功能与机制的研究[D]: [硕士学位论文]. 上海: 中国人民解放军海军军医大学, 2022. https://doi.org/10.26998/d.cnki.gjuyu.2022.000249
|
[30]
|
张庆怡. PKMYT1在食管鳞癌中的表达和机制研究[D]: [硕士学位论文]. 郑州: 郑州大学, 2020.
https://doi.org/10.27466/d.cnki.gzzdu.2020.002778
|
[31]
|
Zhang, Q.Y., Chen, X.Q., Liu, X.C. and Wu, D.M. (2020) PKMYT1 Promotes Gastric Cancer Cell Proliferation and Apoptosis Resistance. OncoTargets and Therapy, 13, 7747-7757. https://doi.org/10.2147/OTT.S255746
|